TG Therapeutics, Inc. (TGTX) — Analysis Summary
TG Therapeutics, Inc. (TGTX) has a market cap of $7.70B with year-over-year revenue growth of +87.3%. Net margin stands at 72.6%. The stock trades at a P/E ratio of 16.7.
Key Takeaways
- Revenue changed +87.3% year-over-year
- Net margin of 72.6%
- P/E ratio of 16.7
Compared to other companies in the PHARMACEUTICAL PREPARATIONS sector, TGTX posted revenue growth of +87.3% and trades at a P/E of 16.7.
Disclaimer: This is not financial advice. Data sourced from SEC EDGAR and Polygon.io. Past performance does not guarantee future results. Always conduct your own research before making investment decisions.